{
  "glycan_biomarkers": [
    {
      "assessed_biomarker_entity": {
        "glycan_entity": "N-glycans",
        "glycan_entity_change": "altered level",
        "glycoprotein_entity_name": "serum proteins",
        "glycoprotein_gene_name": "",
        "glycoprotein_mapped": "Biomarkers, Tumor",
        "glycoenzyme_entity_name": "",
        "glycoenzyme_gene_name": "",
        "glycoenzyme_mapped": ""
      },
      "associated_disease": {
        "disease_name": "cirrhosis",
        "disease_mapped": "",
        "medical_intervention": ""
      },
      "biomarker_role": [
        "diagnostic"
      ],
      "sample": {
        "organism": "Humans",
        "specimen_type": "serum",
        "specimen_mapped": ""
      },
      "evidence": {
        "pmid": "35925813",
        "sentence_in_abstract": "Using the biomarker data model allows the capture of granular information, such as glycans with different levels of abundance in cirrhosis, hepatocellular carcinoma, and transplant groups."
      }
    },
    {
      "assessed_biomarker_entity": {
        "glycan_entity": "N-glycans",
        "glycan_entity_change": "altered level",
        "glycoprotein_entity_name": "serum proteins",
        "glycoprotein_gene_name": "",
        "glycoprotein_mapped": "Biomarkers, Tumor",
        "glycoenzyme_entity_name": "",
        "glycoenzyme_gene_name": "",
        "glycoenzyme_mapped": ""
      },
      "associated_disease": {
        "disease_name": "hepatocellular carcinoma",
        "disease_mapped": "Carcinoma, Hepatocellular",
        "medical_intervention": ""
      },
      "biomarker_role": [
        "diagnostic"
      ],
      "sample": {
        "organism": "Humans",
        "specimen_type": "serum",
        "specimen_mapped": ""
      },
      "evidence": {
        "pmid": "35925813",
        "sentence_in_abstract": "Using the biomarker data model allows the capture of granular information, such as glycans with different levels of abundance in cirrhosis, hepatocellular carcinoma, and transplant groups."
      }
    },
    {
      "assessed_biomarker_entity": {
        "glycan_entity": "N-glycans",
        "glycan_entity_change": "altered level",
        "glycoprotein_entity_name": "serum proteins",
        "glycoprotein_gene_name": "",
        "glycoprotein_mapped": "Biomarkers, Tumor",
        "glycoenzyme_entity_name": "",
        "glycoenzyme_gene_name": "",
        "glycoenzyme_mapped": ""
      },
      "associated_disease": {
        "disease_name": "transplant groups",
        "disease_mapped": "",
        "medical_intervention": ""
      },
      "biomarker_role": [
        "diagnostic"
      ],
      "sample": {
        "organism": "Humans",
        "specimen_type": "serum",
        "specimen_mapped": ""
      },
      "evidence": {
        "pmid": "35925813",
        "sentence_in_abstract": "Using the biomarker data model allows the capture of granular information, such as glycans with different levels of abundance in cirrhosis, hepatocellular carcinoma, and transplant groups."
      }
    }
  ]
}